Monday, 10 December, 2018

Bristol-Myers Squibb Company (NYSE:BMY) Drops Lower -1.20% For Week

Nellie Chapman | 04 February, 2018, 15:59

Renaissance Technologies LLC now owns 13,488,200 shares of the biopharmaceutical company's stock valued at $751,563,000 after buying an additional 7,020,200 shares in the last quarter. Warren Averett Asset Mngmt Limited Liability Co accumulated 16,614 shares. The stock decreased 1.77% or $6.07 during the last trading session, reaching $336.79. (NYSE:AZO) for 2,948 shares., Inc. (NASDAQ:JD) has risen 77.67% since February 3, 2017 and is uptrending.

Shufro Rose & Co Llc increased its stake in Bristol Myers Squibb Co (BMY) by 0.91% based on its latest 2017Q3 regulatory filing with the SEC. Woodstock Corp who had been investing in Bristol for a number of months, seems to be bullish on the $103.90 billion market cap company.

The stock increased 0.32% or $0.2 during the last trading session, reaching $62.8. The stock had a trading volume of 11,718,760 shares, compared to its average volume of 6,440,000.

Bristol-Myers Squibb Company (NYSE:BMY) recently ticked higher on strong volume. It has underperformed by 39.89% the S&P500.

Since September 6, 2017, it had 1 insider purchase, and 2 selling transactions for $646,385 activity. Another trade for 5,300 shares valued at $335,172 was sold by Lynch Thomas J. Jr. Caldarella Joseph C had sold 9,340 shares worth $560,400. Therefore 32% are positive. The stock of Golar LNG Limited (NASDAQ:GLNG) has "Hold" rating given on Friday, January 27 by Nordea. The rating was maintained by Piper Jaffray on Thursday, July 27 with "Hold". Keel Point LLC lifted its holdings in shares of Bristol-Myers Squibb by 0.6% during the 2nd quarter. The rating was maintained by Cowen & Co with "Buy" on Tuesday, December 12. The rating was upgraded by Jefferies to "Buy" on Monday, December 19. BMO Capital Markets maintained it with "Sell" rating and $49.0 target in Wednesday, August 16 report. The company was maintained on Monday, August 14 by Cowen & Co. The stock presently has a consensus rating of "Hold" and an average price target of $65.38.

Investors sentiment increased to 1.03 in 2017 Q3. Its down 0.14, from 1.34 in 2017Q2. It improved, as 33 investors sold THC shares while 57 reduced holdings.

Several hedge funds have recently made changes to their positions in BMY. Credit Suisse Group reiterated a "hold" rating and set a $61.00 target price (up from $58.00) on shares of Bristol-Myers Squibb in a research note on Friday, October 27th. Highbridge Mgmt Ltd Liability Corp has 118,897 shares for 0.11% of their portfolio. France-based Tobam has invested 2.68% in Bristol-Myers Squibb Company (NYSE:BMY). Next Fincl Grp has 21,495 shares for 0.39% of their portfolio. Van Strum And Towne Inc owns 0.13% invested in Bristol-Myers Squibb Company (NYSE:BMY) for 3,204 shares. Lmr Ptnrs Llp invested in 0.05% or 7,308 shares. Louisiana State Employees Retirement Systems accumulated 102,400 shares or 0.31% of the stock. Jnba Fincl Advsrs accumulated 100 shares. Stevens First Principles Inv Advisors invested in 4,472 shares or 0.16% of the stock. Argent Capital Management Lc has invested 0.63% in Bristol-Myers Squibb Company (NYSE:BMY). Overbrook Mngmt reported 16,200 shares or 0.23% of all its holdings. Caspian Capital Lp bought 400,000 shares as the company's stock declined 9.34% while stock markets rallied. After $0.10 actual earnings per share reported by, Inc. for the previous quarter, Wall Street now forecasts -130.00% negative EPS growth. It also upped Genie Energy stake by 4,003 shares and now owns 405,719 shares.

Qv Investors Inc, which manages about $1.19B US Long portfolio, decreased its stake in Johnson & Johnson (NYSE:JNJ) by 35,055 shares to 1,510 shares, valued at $196,000 in 2017Q3, according to the filing. About 3.59 million shares traded. Shares for $5.91 million were sold by AYAT SIMON.

Investors sentiment increased to 1.03 in 2017 Q3. Its the same as in 2017Q2. It is flat, as 69 investors sold SLB shares while 596 reduced holdings. only 105 funds opened positions while 481 raised stakes. Reynders Mcveigh Limited Liability Company stated it has 28,771 shares or 0.24% of all its holdings. Blue Chip Partners Inc. now owns 2,156 shares of the biopharmaceutical company's stock valued at $120,000 after purchasing an additional 15 shares in the last quarter. Atlantic Trust LLC bought a new stake in shares of Bristol-Myers Squibb in the 2nd quarter worth about $111,000. Calamos Wealth Ltd Limited Liability Company has invested 0.13% of its portfolio in Northrop Grumman Corporation (NYSE:NOC). Green Square Ltd Liability Corp invested in 4,890 shares. Ibm Retirement Fund reported 40,956 shares. UBS Group reiterated a "buy" rating and set a $72.00 target price (up previously from $62.00) on shares of Bristol-Myers Squibb in a research report on Friday, October 6th. Moreover, Trexquant Ltd Partnership has 0.44% invested in AutoZone, Inc. Fulton Bancorp Na reported 0.07% stake. 45,778 were accumulated by Dowling Yahnke Limited Com. (NYSE:ZAYO) to report earnings on February, 8. Sands Cap Mngmt Lc owns 17,324 shares for 0% of their portfolio. Lord Abbett Ltd Liability reported 0.31% stake.

Among 37 analysts covering Schlumberger Limited. The stock of Bristol-Myers Squibb Company (NYSE:BMY) has "Hold" rating given on Tuesday, June 14 by Jefferies. Therefore 61% are positive. Bristol-Myers Squibb Company had 69 analyst reports since July 28, 2015 according to SRatingsIntel. BMO Capital Markets maintained the stock with "Market Perform" rating in Wednesday, April 5 report. The company was maintained on Thursday, August 11 by Nomura. Following the acquisition, the director now directly owns 22,000 shares in the company, valued at $1,370,600. On Monday, January 22 the stock rating was maintained by Seaport Global with "Buy". The company was upgraded on Tuesday, May 23 by JP Morgan. The stock of Schlumberger Limited (NYSE:SLB) has "Overweight" rating given on Monday, October 23 by Morgan Stanley. The firm has "Buy" rating by Goldman Sachs given on Tuesday, May 30. Robert W. Baird initiated the shares of BMY in report on Wednesday, April 26 with "Outperform" rating. The rating was maintained by RBC Capital Markets on Wednesday, August 26 with "Buy".

Echostar Corporation-Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.